Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which Illumina will...
Read More »Grail plans to raise $1 billion for liquid biopsy clinical trials
Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors. GRAIL intends to raise additional capital in the Series B financing ...
Read More »A Single Blood Test For All Cancers? Illumina, Bill Gates And Jeff Bezos Launch Startup To Make It Happen
Forbes – What if a simple blood test could detect any cancer early, when it was still easy to treat? It sounds like science fiction. But Illumina ILMN -0.33%, the $24 billion (market cap) biotechnology company that has pioneered cheap, ...
Read More »New England Biolabs’ Library Prep Kit Finds Favor in Researchers’ Analysis of RNA in Circulating Exosomes
by Andrea Anderson at GenomeWeb An analysis aimed at establishing a baseline understanding of the small, exosome-bound RNAs present in typical blood samples is also offering insights into the performance of the existing methods used to make libraries of the ...
Read More »